TriangleFOR PATIENTS · SOURCE READING
Regional chemotherapy and regional immunotherapy
Source: Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. To learn more about chemotherapy, see Chemotherapy to Treat Cancer and Chemotherapy and You: Support for People With Cancer.
Source links and citations
Immunotherapy helps a person’s immune system fight cancer. Learn more about Immunotherapy to Treat Cancer.
Source links and citations
Regional treatment for transitional cell cancer of renal pelvis and ureter is a method of placing the chemotherapy or immunotherapy drug directly into the renal pelvis or the ureter to mainly affect cancer cells in those areas.
Preserved source evidence · Independent clinical review pending · Not medical advice